Tech Company M&A Transactions

GENEWIZ Acquisition

On 9/26/2018, GENEWIZ was acquired by Brooks Automation. The transaction price was $450 million.

Transaction Overview

Company Name
Announced On
9/26/2018
Transaction Type
M&A
Amount
$450,000,000
M&A Terms
The total cash purchase price for the acquisition will be approximately $450 million, subject to working capital and other adjustments.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
115 Corporate Blvd.
South Plainfield, NJ 07080
USA
Email Address
Not Recorded
Overview
GENEWIZ is a contract research organization specializing in DNA sequencing, gene synthesis, plasmid preparation, site-directed mutagenesis, fragment analysis, SNP discovery sequencing, GLP/cGMP regulatory services, next generation sequencing, bioinformatics, and other molecular biology and genomic services.
Profile
GENEWIZ LinkedIn Company Profile
Social Media
GENEWIZ Company Twitter Account
Company News
GENEWIZ News
Facebook
GENEWIZ on Facebook
YouTube
GENEWIZ on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Steve Sun
  Steve Sun LinkedIn Profile  Steve Sun Twitter Account  Steve Sun News  Steve Sun on Facebook
Chief Operating Officer
Amy Liao
  Amy Liao LinkedIn Profile  Amy Liao Twitter Account  Amy Liao News  Amy Liao on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/26/2018: Morphic Holding venture capital transaction
Next: 9/26/2018: MouSensor venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary